OpenURL Connection Search

Select item for more details and to access through your institution.

PREDICTIVE VALUE OF END‐OF‐TREATMENT POSITRON EMISSION TOMOGRAPHY SCAN AFTER DA‐EPOCH‐R IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA. REAL‐LIFE EXPERIENCE.
Published in:
Hematological Oncology, 2019, v. 37, p. 458, doi. 10.1002/hon.135_2631
By:
- Derenzini, E.;
- Ramadan, S.;
- Vanazzi, A.;
- Radice, T.;
- Avenoso, D.;
- Mulè, A.;
- Sammassimo, S.;
- Gigli, F.;
- Iannitto, E.;
- Consoli, U.;
- Patti, C.;
- Tarella, C.
Publication type:
Article
PREDICTIVE VALUE OF END‐OF‐TREATMENT POSITRON EMISSION TOMOGRAPHY SCAN AFTER DA‐EPOCH‐R IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA. REAL‐LIFE EXPERIENCE.
Published in:
Hematological Oncology, 2019, v. 37, p. 458, doi. 10.1002/hon.135_2631
By:
- Derenzini, E.;
- Ramadan, S.;
- Vanazzi, A.;
- Radice, T.;
- Avenoso, D.;
- Mulè, A.;
- Sammassimo, S.;
- Gigli, F.;
- Iannitto, E.;
- Consoli, U.;
- Patti, C.;
- Tarella, C.
Publication type:
Article
Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis.
Published in:
Ecancermedicalscience, 2013, v. 7, p. 1, doi. 10.3332/ecancer.2013.327
By:
- Gardellini, A.;
- Gigli, F.;
- Babic, A.;
- Andreola, G.;
- Radice, D.;
- Sammassimo, S.;
- Martinelli, G.;
- Laszlo, D.
Publication type:
Article
Is there a role for 'modified VAD' in the treatment of multiple myeloma?
Published in:
Ecancermedicalscience, 2009, v. 3, p. 1, doi. 10.3332/ecancer.2009.136
By:
- Agazzi, A.;
- Sammassimo, S.;
- Laszlo, D.;
- Liptrott, S. J.;
- Cascio, R.;
- Alietti, A.;
- Rabascio, C.;
- Mancuso, P.;
- Pruneri, G.
Publication type:
Article
Tissue Microarrays in Diffuse Large B-Cell Lymphomas: Are They Really Able to Identify Distinct Prognostic Groups in Lymphomas of Both Nodal and Extranodal Origin?
Published in:
International Journal of Surgical Pathology, 2011, v. 19, n. 4, p. 417, doi. 10.1177/1066896909345596
By:
- Laszlo, D.;
- Pruneri, G.;
- Andreola, G.;
- Radice, D.;
- Calabrese, L.;
- Rafaniello, P. R.;
- Nassi, L.;
- Sammassimo, S.;
- Alietti, A.;
- Agazzi, A.;
- Vanazzi, A.;
- Martinelli, G.
Publication type:
Article

Found: 5

PREDICTIVE VALUE OF END‐OF‐TREATMENT POSITRON EMISSION TOMOGRAPHY SCAN AFTER DA‐EPOCH‐R IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA. REAL‐LIFE EXPERIENCE.

PREDICTIVE VALUE OF END‐OF‐TREATMENT POSITRON EMISSION TOMOGRAPHY SCAN AFTER DA‐EPOCH‐R IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA. REAL‐LIFE EXPERIENCE.

Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis.

Is there a role for 'modified VAD' in the treatment of multiple myeloma?

Tissue Microarrays in Diffuse Large B-Cell Lymphomas: Are They Really Able to Identify Distinct Prognostic Groups in Lymphomas of Both Nodal and Extranodal Origin?